NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

Rhea-AI Summary

NovaBay Pharmaceuticals (NBY) will announce its financial results for Q1 2022 on May 12, 2022, after market close, followed by a conference call at 4:30 p.m. ET. Participants can pre-register for immediate access or dial in live. A replay of the call will be available from two hours after its conclusion until June 2, 2022. NovaBay focuses on developing and selling products in the eyecare and skincare markets, notably its Avenova antimicrobial spray. The company recently acquired DERMAdoctor, enhancing its skincare portfolio.

Positive

• Scheduled financial results announcement for Q1 2022 boosts transparency.
• Avenova is recognized as the most prescribed antimicrobial lid and lash spray.
• Acquisition of DERMAdoctor expands product offerings to over 30 dermatologist-developed skincare products.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay^® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:		Thursday, May 12, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:		Participants can pre-register for the conference call here:
		Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:		Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
		866-777-2509 from within the U.S.
		412-317-5413 from outside the U.S.

The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through June 2, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 9711049. The webcast will also be archived at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova^® is the most prescribed antimicrobial lid and lash spray in the eyecare market. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBay’s Progress

Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information

For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information

For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005162/en/

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc.

FAQ

When will NovaBay Pharmaceuticals announce its financial results for Q1 2022?

NovaBay Pharmaceuticals will announce its financial results for Q1 2022 on May 12, 2022.

What time is the conference call for NovaBay Pharmaceuticals Q1 results?

The conference call for NovaBay Pharmaceuticals' Q1 results is scheduled for 4:30 p.m. ET on May 12, 2022.

How can I access the NovaBay Pharmaceuticals conference call?

You can access the NovaBay Pharmaceuticals conference call by pre-registering online or dialing in using the provided numbers.

What is Avenova and its significance in the eyecare market?

Avenova is the most prescribed antimicrobial lid and lash spray in the eyecare market, indicating its market dominance.

What acquisition did NovaBay Pharmaceuticals make to expand its product line?

NovaBay Pharmaceuticals acquired DERMAdoctor in November 2021, expanding its skincare product offerings.